Xinyu Shao Selected Research

Xinyu Shao Research Topics

8	Neoplasms (Cancer) 01/2021 - 05/2013
6	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2019
2	Stomach Neoplasms (Stomach Cancer) 03/2019 - 10/2018
1	Infections 01/2022
1	Diarrhea 01/2022
1	Inflammation (Inflammations) 12/2021
1	Colonic Neoplasms (Colon Cancer) 12/2021
1	Adenoma (Adenomas) 01/2021
1	Paraplegia (Spastic Paraplegia) 01/2021
1	Polyps 01/2021
1	Carcinogenesis 01/2021
1	Dysbiosis 01/2020
1	Obesity 01/2019
1	Insulin Resistance 01/2018
1	Diabetes Mellitus 01/2015
1	Arthrogryposis renal dysfunction cholestasis syndrome 05/2013
1	Breast Neoplasms (Breast Cancer) 05/2013
1	Type 2 Diabetes Mellitus (MODY) 04/2009

4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2021 - 01/2020
2	Fibroblast Growth Factor 1 (FGF-1)IBA 01/2021 - 01/2021
2	LipidsIBA 01/2019 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 04/2009
1	Progesterone FDA LinkGeneric 01/2022
1	Interleukin-18 (Interleukin 18)IBA 12/2021
1	Butyrates (Butyrate)IBA 12/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	tissue-factor-pathway inhibitor 2 (PP5)IBA 01/2021
1	WD repeat containing planar cell polarity effectorIBA 01/2021
1	Aldo-Keto Reductase Family 1 member B10IBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	VimentinIBA 01/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	NLR ProteinsIBA 01/2020
1	Zinc Finger Protein GLI1IBA 03/2019
1	AlbuminsIBA 01/2019
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2019
1	CreatinineIBA 01/2019
1	Chemotactic FactorsIBA 01/2019
1	EnzymesIBA 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2019
1	Trastuzumab (Herceptin)FDA Link 10/2018
1	Indicators and Reagents (Reagents)IBA 10/2018
1	Exenatide (Byetta)FDA Link 01/2018
1	Metformin (Glucophage)FDA LinkGeneric 01/2018
1	Insulin Glargine (Lantus)FDA Link 01/2018
1	Insulin (Novolin)FDA Link 01/2015
1	Cobalt-60IBA 05/2013
1	Hepatocyte Nuclear Factor 1-betaIBA 04/2009